Explore All Access
Check if your research matches the topics covered in Cancer Drug Discovery and Development?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Cancer Drug Discovery and Development : Impact Factor & More
eISSN: 2196-9914pISSN: 2196-9906
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Cancer Drug Discovery and Development Key Metrics
CiteScore 
1.5
SJR
Q4Oncology
Cancer Drug Discovery and Development Journal Specifications
| Overview | |
| Publisher | Springer Nature |
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in Cancer Drug Discovery and Development ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Drug Discovery and Development
Tumor Infiltrating Lymphocytes (TIL): From Bench to Bedside
- 1 Jan 2022
Viral Cytotoxic T Lymphocytes (CTLs): From Bench to Bedside
- 1 Jan 2022
Gene and Cellular Immunotherapy for Cancer
- 1 Jan 2022
Combination Therapeutics with CAR-T Cell Therapy
- 1 Jan 2022
T-Cell Receptor (TCR) Engineered Cells and Their Transition to the Clinic
- 1 Jan 2022
Safety Switches Used for Cellular Therapies
- 1 Jan 2022
Tumor Infiltrating Lymphocytes (TIL): From Bench to Bedside
- 1 Jan 2022
Viral Cytotoxic T Lymphocytes (CTLs): From Bench to Bedside
- 1 Jan 2022
Gene and Cellular Immunotherapy for Cancer
- 1 Jan 2022
Combination Therapeutics with CAR-T Cell Therapy
- 1 Jan 2022
T-Cell Receptor (TCR) Engineered Cells and Their Transition to the Clinic
- 1 Jan 2022
Safety Switches Used for Cellular Therapies
- 1 Jan 2022
FAQs on Cancer Drug Discovery and Development
How many articles did Cancer Drug Discovery and Development publish last year? 
In 2023, Cancer Drug Discovery and Development publsihed undefined articles.
What is the eISSN & pISSN for Cancer Drug Discovery and Development?
For Cancer Drug Discovery and Development, eISSN is 2196-9914 and pISSN is 2196-9906.
What is Citescore for Cancer Drug Discovery and Development?
Citescore for Cancer Drug Discovery and Development is 1.5.
What is the SJR for Cancer Drug Discovery and Development?
SJR for Cancer Drug Discovery and Development is Q4.
Who is the publisher of Cancer Drug Discovery and Development?
Springer Nature is the publisher of Cancer Drug Discovery and Development.